Literature DB >> 30887293

The Effect of Pancreaticojejunostomy Technique on Fistula Formation Following Pancreaticoduodenectomy in the Soft Pancreas.

Lisbi Rivas1, Sara L Zettervall2, Tammy Ju2, Samantha Olafson2, Jeremy Holzmacher2, Paul P Lin2, Khashayar Vaziri2.   

Abstract

INTRODUCTION: A soft pancreas has been associated with an increased risk of post-operative pancreatic fistula formation. Few studies have evaluated the effect of anastomotic technique (duct to mucosa vs invagination) on fistula formation. This study aims to compare the effect of anastomotic technique on fistula formation among patients with a soft pancreas in a large multiinstitutional database.
METHODS: The targeted pancreas module of the American College of Surgeons-National Surgical Quality Improvement Program (NSQIP) Database was used. All patients with a soft pancreas who underwent pancreaticoduodenectomy from 2014 to 2015 were identified. Demographic data, comorbid conditions, operative variables, and 30-day outcomes were compared using univariate and multivariable analyses.
RESULTS: A total of 975 patients met inclusion criteria. Eight-hundred fifty four (88%) underwent a duct to mucosa pancreaticojejunostomy technique and 121 (12%) underwent invagination. Patients who underwent invagination had higher 30-day mortality (5.8% vs 1.4%, p < 0.01), higher fistula formation (38% vs 25%, p < 0.01), and more often had percutaneous drain placement post-operatively (27% vs 14%, p < 0.01). Following multivariable analysis, invagination remained associated with pancreatic fistula formation (OR 2.5, CI 1.4-4.3) and post-operative percutaneous drain placement (OR 1.8, CI 1.1-2.9).
CONCLUSION: Invagination technique for pancreaticojejunostomy in patients with a soft pancreas is associated with increased rates of pancreatic fistula. Surgeons should consider utilizing a duct to mucosa technique when feasible to decrease morbidity following pancreaticoduodenectomy in this patient population.

Entities:  

Keywords:  NSQIP; Pancreaticojejunostomy; Post-operative pancreatic fistula

Year:  2019        PMID: 30887293     DOI: 10.1007/s11605-019-04164-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Duct-to-Mucosa vs Invagination for Pancreaticojejunostomy after Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial from a Single Surgeon.

Authors:  Xueli Bai; Qi Zhang; Shunliang Gao; Jianying Lou; Guogang Li; Yun Zhang; Tao Ma; Yibo Zhang; Yuanliang Xu; Tingbo Liang
Journal:  J Am Coll Surg       Date:  2015-10-21       Impact factor: 6.113

Review 2.  Duct-to-Mucosa Versus Invagination Pancreaticojejunostomy Following Pancreaticoduodenectomy: a Systematic Review and Meta-Analysis.

Authors:  Jie Hua; Zhigang He; Daohai Qian; Hongbo Meng; Bo Zhou; Zhenshun Song
Journal:  J Gastrointest Surg       Date:  2015-08-12       Impact factor: 3.452

Review 3.  Postoperative pancreatic fistula: an international study group (ISGPF) definition.

Authors:  Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

4.  Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Manabu Kawai; Satoshi Kondo; Hiroki Yamaue; Keita Wada; Keiji Sano; Fuyuhiko Motoi; Michiaki Unno; Sohei Satoi; A-Hon Kwon; Takashi Hatori; Masakazu Yamamoto; Joe Matsumoto; Yoshiaki Murakami; Ryuichiro Doi; Masahiro Ito; Shuichi Miyakawa; Hiroyuki Shinchi; Shoji Natsugoe; Hisatoshi Nakagawara; Tetsuo Ohta; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-07       Impact factor: 7.027

5.  A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively.

Authors:  Ulrich Friedrich Wellner; Gian Kayser; Hryhoriy Lapshyn; Olivia Sick; Frank Makowiec; Jens Höppner; Ulrich Theodor Hopt; Tobias Keck
Journal:  HPB (Oxford)       Date:  2010-12       Impact factor: 3.647

6.  Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula.

Authors:  John W Lin; John L Cameron; Charles J Yeo; Taylor S Riall; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Risk prediction for development of pancreatic fistula using the ISGPF classification scheme.

Authors:  Wande B Pratt; Mark P Callery; Charles M Vollmer
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

8.  Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.

Authors:  Adam C Berger; Thomas J Howard; Eugene P Kennedy; Patricia K Sauter; Maryanne Bower-Cherry; Sarah Dutkevitch; Terry Hyslop; C Max Schmidt; Ernest L Rosato; Harish Lavu; Atilla Nakeeb; Henry A Pitt; Keith D Lillemoe; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2009-05       Impact factor: 6.113

9.  Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size.

Authors:  Yasuyuki Suzuki; Yasuhiro Fujino; Yasuki Tanioka; Kunihiko Hiraoka; Moriatsu Takada; Tetsuo Ajiki; Yoshifumi Takeyama; Yonson Ku; Yoshikazu Kuroda
Journal:  Arch Surg       Date:  2002-09

10.  Fatty pancreas: a factor in postoperative pancreatic fistula.

Authors:  Abhishek Mathur; Henry A Pitt; Megan Marine; Romil Saxena; C Max Schmidt; Thomas J Howard; Attila Nakeeb; Nicholas J Zyromski; Keith D Lillemoe
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

View more
  1 in total

Review 1.  Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy.

Authors:  Hua Hai; Zhuyin Li; Ziwei Zhang; Yao Cheng; Zuojin Liu; Jianping Gong; Yilei Deng
Journal:  Cochrane Database Syst Rev       Date:  2022-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.